ROCHE FINANCE LTD's Net Worth
-$3.15 Billion
Who is ROCHE FINANCE LTD?
ROCHE FINANCE LTD does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Senseonics Holdings, Inc., Allakos Inc., Entrada Therapeutics, Inc., Jasper Therapeutics, Inc., Pandion Therapeutics, Inc., Foundation Medicine, Inc., AILERON THERAPEUTICS INC, and Aligos Therapeutics, Inc..
SEC CIK
ROCHE FINANCE LTD's CIK is 0001053942
Past Insider Trading and Trends
2018 was ROCHE FINANCE LTD's most active year for acquiring shares with 3 total transactions. ROCHE FINANCE LTD's most active month to acquire stocks was the month of June. 2017 was ROCHE FINANCE LTD's most active year for disposing of shares, totalling 4 transactions. ROCHE FINANCE LTD's most active month to dispose stocks was the month of June. 2018 saw ROCHE FINANCE LTD paying a total of $2,222,280,699.00 for 20,831,750 shares, this is the most they've acquired in one year. In 2023 ROCHE FINANCE LTD cashed out on 75,000 shares for a total of $141,750.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Senseonics Holdings, Inc. (SENS) Snapshot price: $0.5318
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Allakos Inc. (ALLK) Snapshot price: $1.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 4.61M |
—
|
—
| 4.61M |
Jul 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Entrada Therapeutics, Inc. (TRDA) Snapshot price: $14.72
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.81M |
—
|
—
| 2.81M |
Nov 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Foundation Medicine, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +78.73% | 16.22M |
$137.00 | $2,222,280,699.00 | 36.83M |
Jul 31
| |||
Form 4
|
∞
| 20.6M |
$50.00 | $1,030,214,400.00 | 20.6M |
Apr 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Jasper Therapeutics, Inc. (JSPR) Snapshot price: $11.78
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.62% | -75.00K |
$1.89 | -$141,750.00 | 4.55M |
Jan 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||